INmune Bio Dividend
Dividend criteria checks 0/6
INmune Bio does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Payout ratio
| Industry average yield | 2.9% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Earnings per share | -US$1.52 |
| Dividend yield forecast in 3Y | n/a |
Recent dividend updates
No updates
Recent updates
Is INmune Bio (NASDAQ:INMB) Using Debt Sensibly?
Jan 19
Is INmune Bio (NASDAQ:INMB) Using Debt In A Risky Way?
Sep 04Is INmune Bio (NASDAQ:INMB) Using Too Much Debt?
May 12Here's Why INmune Bio (NASDAQ:INMB) Can Manage Its Debt Despite Losing Money
Jan 16Here's Why INmune Bio (NASDAQ:INMB) Can Manage Its Debt Despite Losing Money
Jul 11INmune Bio: Possibly The Once In A Lifetime Dip
May 25INmune Bio: Speculative Biotech With 2 Solid Potential Approaches To Treating AD And Solid Tumors
Apr 05Is INmune Bio (NASDAQ:INMB) A Risky Investment?
Mar 25Is INmune Bio (NASDAQ:INMB) Using Too Much Debt?
Dec 02INmune Bio A No-Brainer Investment
Oct 13INmune Bio: High-Risk High-Reward Alzheimer's Play
Aug 18Our Bullish Take On INmune Bio's Drug Pipeline
Aug 12INmune Bio: Underfollowed AD Player With Very Bullish August Momentum
Jul 13Companies Like INmune Bio (NASDAQ:INMB) Are In A Position To Invest In Growth
Jun 25INmune enters $15M credit facility to fund purchase of Xencor option
Jun 14INmune Bio (NASDAQ:INMB) Is In A Strong Position To Grow Its Business
Mar 01What Kind Of Investors Own Most Of INmune Bio, Inc. (NASDAQ:INMB)?
Jan 05
Here's Why We're Not Too Worried About INmune Bio's (NASDAQ:INMB) Cash Burn Situation
Dec 01INmune Bio EPS misses by $0.19
Nov 05Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if INMB's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if INMB's dividend payments have been increasing.
Dividend Yield vs Market
| INmune Bio Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (INMB) | n/a |
| Market Bottom 25% (US) | 1.6% |
| Market Top 25% (US) | 4.8% |
| Industry Average (Biotechs) | 2.9% |
| Analyst forecast in 3 Years (INMB) | n/a |
Notable Dividend: Unable to evaluate INMB's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate INMB's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate INMB's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as INMB has not reported any payouts.